Find uplifting stories about heroes, innovations, and solutions
12580 results for "melanoma breakthrough"
A personalized mRNA vaccine combined with immunotherapy stopped melanoma from returning in 69% of patients over five years, nearly double the rate of standard treatment alone. The breakthrough could transform how doctors fight not just skin cancer, but many other cancers too.
Two Australian scientists transformed melanoma from a death sentence into a treatable disease, saving hundreds of lives each year. Their breakthrough immunotherapy approach now gives patients a 55% survival rate where there was once almost no hope.
A personalized mRNA vaccine combined with immunotherapy reduced melanoma recurrence or death by nearly half over five years. The breakthrough treatment, developed by Merck and Moderna, teaches the immune system to recognize and attack cancer cells.
A personalized mRNA cancer vaccine just achieved its first major trial success, stopping melanoma from returning in patients who had tumors removed. The breakthrough could launch an entirely new way to fight cancer by 2027.
A personalized cancer vaccine combined with immunotherapy has kept nearly 70% of melanoma patients cancer-free five years after surgery. The breakthrough offers new hope for preventing one of the deadliest skin cancers from coming back.
Researchers discovered how melanoma cells bypass aging to become deadly, uncovering a hidden genetic partnership that keeps tumors dividing indefinitely. The breakthrough reveals a potential new target for future cancer treatments. #
Scientists at UC San Diego discovered that catestatin, a naturally occurring peptide in our bodies, can slow melanoma growth and overcome drug resistance. This breakthrough could transform how doctors treat one of the deadliest forms of skin cancer.
A personalized mRNA cancer vaccine combined with existing treatment stopped melanoma from returning in a major clinical trial. The breakthrough could open a powerful new way to fight cancer using the same technology that powered COVID vaccines.
A personalized mRNA cancer vaccine developed by Moderna and Merck has shown remarkable success in preventing melanoma from returning. The breakthrough sent Moderna's stock soaring 90% and offers new hope for treating cancer beyond COVID vaccines.
A personalized mRNA cancer vaccine combined with immunotherapy kept nearly 7 in 10 high-risk melanoma patients cancer-free five years later. The breakthrough cuts the risk of cancer returning or spreading by nearly half.
Researchers in Finland discovered how to potentially break the inflammatory cycle that helps aggressive skin cancer spread. The breakthrough could lead to new treatments that stop melanoma cells from communicating with immune cells that accidentally help tumors grow.
A New Orleans patient became the first in Louisiana to receive a breakthrough melanoma treatment that saves their eye, eliminating the need for removal or distant travel. The procedure offers new hope for eye cancer patients across the Gulf Coast.
A personalized cancer treatment using the same technology behind COVID vaccines just proved it can significantly reduce melanoma recurrence in the largest trial of its kind. Experts are calling it a breakthrough that could transform how we fight cancer.
A personalized mRNA cancer vaccine has shown remarkable success in preventing melanoma from returning and spreading in late-stage trials. Thousands of high-risk melanoma patients could benefit as soon as next year if regulators approve the groundbreaking treatment.
A groundbreaking cancer therapy now lets doctors turn advanced melanoma tumors into personalized healing machines. The FDA-approved TIL therapy harnesses immune cells from a patient's own tumor to fight back against the disease.
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.
A personalized mRNA vaccine combined with immunotherapy slashed skin cancer recurrence rates in over 1,000 high-risk melanoma patients. It's the first late-stage trial success for mRNA cancer treatment, opening new hope for patients worldwide.
After years of setbacks, a new treatment for advanced melanoma just won FDA approval, giving patients a powerful option when other therapies have failed. The drug could help thousands facing one of the deadliest forms of skin cancer.
After 12 years and multiple melanoma diagnoses, Joe Eastin faced his toughest challenge when the cancer spread to his bones. Cutting-edge immunotherapy shrank his tumor by 50% in just three months.
Jenney was diagnosed with stage 4 metastatic melanoma, a cancer that once meant almost certain death. Thanks to immunotherapy, she had no evidence of disease after just five months of treatment.
Showing 20 of 12580